312 related articles for article (PubMed ID: 1346476)
1. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.
Chin KV; Ueda K; Pastan I; Gottesman MM
Science; 1992 Jan; 255(5043):459-62. PubMed ID: 1346476
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants.
Nguyen KT; Liu B; Ueda K; Gottesman MM; Pastan I; Chin KV
Oncol Res; 1994; 6(2):71-7. PubMed ID: 7949467
[TBL] [Abstract][Full Text] [Related]
3. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.
Sampath J; Sun D; Kidd VJ; Grenet J; Gandhi A; Shapiro LH; Wang Q; Zambetti GP; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39359-67. PubMed ID: 11483599
[TBL] [Abstract][Full Text] [Related]
5. A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase.
Cornwell MM; Smith DE
J Biol Chem; 1993 Jul; 268(21):15347-50. PubMed ID: 8101839
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Mdr1 isoforms in a p53-deficient mouse model.
Bush JA; Li G
Carcinogenesis; 2002 Oct; 23(10):1603-7. PubMed ID: 12376467
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
[TBL] [Abstract][Full Text] [Related]
8. MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases.
de Kant E; Heide I; Thiede C; Herrmann R; Rochlitz CF
J Cancer Res Clin Oncol; 1996; 122(11):671-5. PubMed ID: 8898977
[TBL] [Abstract][Full Text] [Related]
9. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.
Kohno K; Sato S; Takano H; Matsuo K; Kuwano M
Biochem Biophys Res Commun; 1989 Dec; 165(3):1415-21. PubMed ID: 2575381
[TBL] [Abstract][Full Text] [Related]
10. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress.
Miyazaki M; Kohno K; Uchiumi T; Tanimura H; Matsuo K; Nasu M; Kuwano M
Biochem Biophys Res Commun; 1992 Sep; 187(2):677-84. PubMed ID: 1356336
[TBL] [Abstract][Full Text] [Related]
11. Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter.
Uchiumi T; Kohno K; Tanimura H; Hidaka K; Asakuno K; Abe H; Uchida Y; Kuwano M
FEBS Lett; 1993 Jul; 326(1-3):11-6. PubMed ID: 8100781
[TBL] [Abstract][Full Text] [Related]
12. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
[TBL] [Abstract][Full Text] [Related]
13. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
14. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.
Zambetti GP; Olson D; Labow M; Levine AJ
Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319
[TBL] [Abstract][Full Text] [Related]
15. P-glycoproteins in pathology: the multidrug resistance gene family in humans.
Weinstein RS; Kuszak JR; Kluskens LF; Coon JS
Hum Pathol; 1990 Jan; 21(1):34-48. PubMed ID: 1967244
[TBL] [Abstract][Full Text] [Related]
16. Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia.
Schaich M; Illmer T
Leuk Lymphoma; 2002 Jul; 43(7):1345-54. PubMed ID: 12389613
[TBL] [Abstract][Full Text] [Related]
17. Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis.
Deguin-Chambon V; Vacher M; Jullien M; May E; Bourdon JC
Oncogene; 2000 Nov; 19(51):5831-41. PubMed ID: 11127813
[TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
19. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents.
Thottassery JV; Zambetti GP; Arimori K; Schuetz EG; Schuetz JD
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):11037-42. PubMed ID: 9380755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
